No Arabic abstract
First investigations regarding dosimetric properties of the hybrid, pixelated, photon-counting Dosepix detector in a pulsed photon field (RQR8) for the personal dose equivalent $Hmathrm{_p(10)}$ are presented. The influence quantities such as pulse duration and dose rate were varied, and their responses were compared to the legal limits provided in PTB-A 23.2. The variation of pulse duration at a nearly constant dose rate of 3.7$,$Sv/h shows a flat response around 1.0 from 3.6$,$s down to 2$,$ms. A response close to 1.0 is achieved for dose rates from 0.07$,$mSv/h to 35$,$Sv/h for both pixel sizes. Above this dose rate, the large pixels (220$,mathrm{mu}$m edge length) are below the lower limit. The small pixels (55$,mathrm{mu}$m edge length) stay within limits up to 704$,$Sv/h. The count rate linearity is compared to previous results, confirming the saturating count rate for high dose rates.
We present the first evaluation of a recently developed silicon-strip detector for photon-counting dual-energy breast tomosynthesis. The detector is well suited for tomosynthesis with high dose efficiency and intrinsic scatter rejection. A method was developed for measuring the spatial resolution of a system based on the detector in terms of the three-dimensional modulation transfer function (MTF). The measurements agreed well with theoretical expectations, and it was seen that depth resolution was won at the cost of a slightly decreased lateral resolution. This may be a justifiable trade-off as clinical images acquired with the system indicate improved conspicuity of breast lesions. The photon-counting detector enables dual-energy subtraction imaging with electronic spectrumsplitting. This improved the detectability of iodine in phantom measurements, and the detector was found to be stable over typical clinical acquisition times. A model of the energy resolution showed that further improvements are within reach by optimization of the detector.
While spatial dose conformity delivered to a target volume has been pushed to its practical limits with advanced treatment planning and delivery, investigations in novel temporal dose delivery are unfolding new mechanisms. Recent advances in ultra-high dose radiotherapy, abbreviated as FLASH, indicate the potential for reduction in healthy tissue damage while preserving tumor control. FLASH therapy relies on very high dose rate of > 40Gy/sec with sub-second temporal beam modulation, taking a seemingly opposite direction from the conventional paradigm of fractionated therapy. FLASH brings unique challenges to dosimetry, beam control, and verification, as well as complexity of radiobiological effective dose through altered tissue response. In this review, we compare the dosimetric methods capable of operating under high dose rate environments. Due to excellent dose-rate independence, superior spatial (~<1 mm) and temporal (~ns) resolution achievable with Cherenkov and scintillation-based detectors, we show that luminescent detectors have a key role to play in the development of FLASH-RT, as the field rapidly progresses towards clinical adaptation. Additionally, we show that the unique ability of certain luminescence-based methods to provide tumor oxygenation maps in real-time with submillimeter resolution can elucidate the radiobiological mechanisms behind the FLASH effect. In particular, such techniques will be crucial for understanding the role of oxygen in mediating the FLASH effect.
SPECT systems using pinhole apertures permit radiolabeled molecular distributions to be imaged in vivo in small animals. Nevertheless studying cardiovascular diseases by means of small animal models is very challenging. Specifically, submillimeter spatial resolution, good energy resolution and high sensitivity are required. We designed what we consider the optimal radionuclide detector system for this task. It should allow studying both detection of unstable atherosclerotic plaques and monitoring the effect of therapies. Using mice is particularly challenging in situations that require several intravenous injections of radiotracers, possibly for week or even months, in chronically ill animals. Thus, alternative routes of delivering the radiotracer in tail vein should be investigated. In this study we have performed preliminary measurements of detection of atherosclerotic plaques in genetically modified mice with high-resolution prototype detector. We have also evaluated the feasibility of assessing left ventricular perfusion by intraperitoneal delivering of MIBI-Tc in healthy mice.
The possibility to separate signals caused by 511 keV photons created in annihilation of electron-positron pairs and the so-called prompt photons from nuclei de- excitation is investigated. It could potentially be used to improve the quality of reconstructed images in the J-PET scanner in 2+1 photon tomography. Firstly, a research is conducted for several radioisotopes that decay via b{eta}+ decay followed by de-excitation of an excited nucleus. Efficiency, purity and false positive rate are calculated for each isotope as a function of energy deposited threshold, with a hypothesis that signals caused by 511 keV photons deposit smaller values of energy than 1 z 13the selected threshold, while prompt photons deposit larger energy than the threshold. Analysis of the results accompanied with physical properties of radioisotopes suggests using 44 Sc, which is the most promising candidate for medical applications. With the use of GATE and J-POS simulation software, in-phantom scattering was introduced and the best energy deposited threshold value was estimated to be approximately 375 keV. It corresponds to almost 100% efficiency for 511 keV signals, 75% purity for 511 keV photons, and approximately 70% efficiency and purity for prompt photons.
We control using bright light an actively-quenched avalanche single-photon detector. Actively-quenched detectors are commonly used for quantum key distribution (QKD) in the visible and near-infrared range. This study shows that these detectors are controllable by the same attack used to hack passively-quenched and gated detectors. This demonstrates the generality of our attack and its possible applicability to eavsdropping the full secret key of all QKD systems using avalanche photodiodes (APDs). Moreover, the commercial detector model we tested (PerkinElmer SPCM-AQR) exhibits two new blinding mechanisms in addition to the previously observed thermal blinding of the APD, namely: malfunctioning of the bias voltage control circuit, and overload of the DC/DC converter biasing the APD. These two new technical loopholes found just in one detector model suggest that this problem must be solved in general, by incorporating generally imperfect detectors into the security proof for QKD.